Article Information
History
- March 17, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Amanda P. Waller, PhD1,
- Jonathan P. Troost, PhD2,
- Samir V. Parikh, MD3,
- Katelyn J. Wolfgang, BS1,
- Brad H. Rovin, MD3,
- Marvin T. Nieman, PhD4,
- William E. Smoyer, MD1,5,
- Matthias Kretzler, MD6,
- Bryce A. Kerlin, MD*,1,7,
- for The NEPTUNE Investigators8
- 1Center for Clinical and Translational Research, Abigail Wexner Research Institute at Nationwide Children’s, Columbus, Ohio, USA
- 2Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, MI, USA
- 3Division of Nephrology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, USA
- 4Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio, USA
- 5Division of Nephrology, Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA
- 6Departments of Internal Medicine and Computational Medicine and Bioinformatics, University of Michigan School of Medicine, Ann Arbor, Michigan, USA
- 7Division of Hematology/Oncology/Blood & Marrow Transplantation, Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA
- ↵*Corresponding Author: Bryce A. Kerlin, MD, Center for Clinical & Translational Research, The Abigail Wexner Research Institute at Nationwide Children’s, 700 Children’s Dr., W325, Columbus, OH 43205, P: 614-355-2729, F: 614-722-3330, Bryce.Kerlin{at}NationwideChildrens.org
Posted March 17, 2020.
Nephrotic Syndrome Disease Activity Predicts Severity of the Associated Hypercoagulopathy
